Schali.swiss
Tailored R&D Solutions for Science and Industry

Customised, innovative solutions for scientific laboratories, universities, tenderers, and consulting R&D companies

Header Background

Tailored R&D Solutions from Concept to Commercial Strategy

From the conceptualization of the partner's ideas to the solution through our various services: We offer tailored solutions for any stage of the research and development process—whether it's support for individual phases, a group of phases, or a comprehensive R&D solution.

Our expertise includes life cycle extension strategies for top-performing drugs, where regulatory authorities approve the rebranding or repurposing of the drug under a bioequivalence protocol. These solutions also ensure extended patent protection for the bioequivalent drug.

50 Years of Innovation: Expert Consulting and Custom API Solutions with Cyclodextrins at the Core

Cyclolab boasts 50 years of consulting experience to the global pharmaceutical industry. As a pioneer in chemical modification of TOP APIs and formulations, we are specialized in custom synthesis, development, scale-up processes and method transfers. Our extensive offerings include the largest library of cyclodextrins, including cross-linked CD polymers.

Header Background

Cyclolab provides integrated services all the way from the discovery phase of drug development in new drug series and dosage forms to preclinical, all clinical phases and technology transfer phase.

Advantages for R&D Participants:

Access to a comprehensive library of top APIs, including detailed data on their properties and chemical modifications. Support for custom formulation development, scale-up, and method transfer. Comparative analyses demonstrating the superior efficacy, safety, and patent advantages of Cyclolab’s solutions versus leading APIs and marketed drugs. Evaluation of different drug delivery forms to identify the most therapeutically effective approach. Benchmarking against top global drugs, including those still in development.
Icon

Preclinical studies phase

A. Pharmacological studies;
B. Toxicological studies and Pharmacological studies (for Customer’s API; for adjuvant, excipient)

CTA/IND phase

A.CRO company from the QD Schali Swiss Collaboration practice - will accelerate the start of registration of the drug;
B.CRO of Client with services/consultation from CRO from QD Schali Swiss cooperation practice
Icon

Phase I of clinical trials

Provided by Cyclolab, Swiss, with securing approvals for Phase II; Phase III clinical trials
Provided guarantee of registration of an effective drug
Icon

Phase II, III of clinical trials

Icon

Commercial registrations of the products

A.pharm drugs;
B.medical devices;
C.food supplements; D.cosmetics

Commercialisation of a product

Select disease(s) - get solutions

For your convenience, we invite you to explore application options before registration and select relevant nosologies.
To make informed decisions on our pharmaceutical technologies and commercial terms, visit our nosology-specific pages and complete the Application Form.
After submitting the form, you will receive detailed analytics from pre-clinical to post-clinical phases and analytical reports with potential cooperation offers.

Subscription

Get the latest news

By confirming my subscription, I agree to receive the newsletter.